These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7129754)
1. Statistical molecular model for hydrated peptides. Application to angiotensin II analogs. Demonte JP Int J Pept Protein Res; 1982 Sep; 20(3):188-93. PubMed ID: 7129754 [TBL] [Abstract][Full Text] [Related]
2. Transport of angiotensin peptides across the Caco-2 monolayer. Chua HL; Jois S; Sim MK; Go ML Peptides; 2004 Aug; 25(8):1327-38. PubMed ID: 15350701 [TBL] [Abstract][Full Text] [Related]
3. Evidences for the action mechanism of angiotensin II and its analogs on Plasmodium sporozoite membranes. Torres MD; Silva AF; Alves FL; Capurro ML; Miranda A; Cordeiro RM; Oliveira Junior VX J Pept Sci; 2016 Mar; 22(3):132-42. PubMed ID: 26856687 [TBL] [Abstract][Full Text] [Related]
4. The space structure of a conformationally labile oligopeptide in solution: angiotensin. Nikiforovich GV; Vesterman B; Betins J; Podins L J Biomol Struct Dyn; 1987 Jun; 4(6):1119-35. PubMed ID: 3270538 [TBL] [Abstract][Full Text] [Related]
5. Antiplasmodial activity study of angiotensin II via Ala scan analogs. Silva AF; Bastos EL; Torres MD; Costa-da-Silva AL; Ioshino RS; Capurro ML; Alves FL; Miranda A; Vieira Rde F; Oliveira VX J Pept Sci; 2014 Aug; 20(8):640-8. PubMed ID: 24817179 [TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin II Ala-scan analogs in erythrocytic cycle of Plasmodium falciparum (in vitro) and Plasmodium gallinaceum (ex vivo). Silva AF; de Souza Silva L; Alves FL; Der TorossianTorres M; de SáPinheiro AA; Miranda A; LaraCapurro M; Oliveira VX Exp Parasitol; 2015 Jun; 153():1-7. PubMed ID: 25720804 [TBL] [Abstract][Full Text] [Related]
8. Conformation of the central sequence of angiotensin II and analogs. Sakarellos C; Lintner K; Piriou F; Fermandjian S Biopolymers; 1983 Feb; 22(2):663-87. PubMed ID: 6838994 [No Abstract] [Full Text] [Related]
9. Comparison of the solution structures of angiotensin I & II. Implication for structure-function relationship. Spyroulias GA; Nikolakopoulou P; Tzakos A; Gerothanassis IP; Magafa V; Manessi-Zoupa E; Cordopatis P Eur J Biochem; 2003 May; 270(10):2163-73. PubMed ID: 12752436 [TBL] [Abstract][Full Text] [Related]
10. A study of the anti-plasmodium activity of angiotensin II analogs. Chamlian M; Bastos EL; Maciel C; Capurro ML; Miranda A; Silva AF; Torres MD; Oliveira VX J Pept Sci; 2013 Sep; 19(9):575-80. PubMed ID: 23893516 [TBL] [Abstract][Full Text] [Related]
11. Circular-dichroism spectra of truncated and other analogs of angiotensin II. Greff D; Fermandjian S; Fromageot P; Khosla MC; Smeby RR; Bumpus FM Eur J Biochem; 1976 Jan; 61(1):297-305. PubMed ID: 1245187 [TBL] [Abstract][Full Text] [Related]
12. Circular dichroism studies of angiotensin II and analogues: effects of primary sequence, solvent, and pH on the side-chain conformation. Lintner K; Fermandjian S; Fromageot P; Khosla MC; Smeby RR; Bumpus FM Biochemistry; 1977 Feb; 16(4):806-12. PubMed ID: 13825 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparum. Torres MD; Silva AF; de Souza Silva L; de Sá Pinheiro AA; Oliveira VX J Pept Sci; 2015 Jan; 21(1):24-8. PubMed ID: 25420772 [TBL] [Abstract][Full Text] [Related]
14. Preferred conformations of cyclic Ac-Cys-Pro-Xaa-Cys-NHMe peptides: a model for chain reversal and active site of disulfide oxidoreductase. Park HS; Kim C; Kang YK Biophys Chem; 2003 Aug; 105(1):89-104. PubMed ID: 12932582 [TBL] [Abstract][Full Text] [Related]
15. Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs. Krishnan R; Hanesworth JM; Wright JW; Harding JW Peptides; 1999; 20(8):915-20. PubMed ID: 10503768 [TBL] [Abstract][Full Text] [Related]
16. Conformational energy studies of beta-sheets of model silk fibroin peptides. I. Sheets of poly(Ala-Gly) chains. Fossey SA; Némethy G; Gibson KD; Scheraga HA Biopolymers; 1991 Nov; 31(13):1529-41. PubMed ID: 1814502 [TBL] [Abstract][Full Text] [Related]
17. Highly potential antiplasmodial restricted peptides. Marcelo Der Torossian T; Silva AF; Alves FL; Capurro ML; Miranda A; Vani Xavier O Chem Biol Drug Des; 2015 Feb; 85(2):163-71. PubMed ID: 24800635 [TBL] [Abstract][Full Text] [Related]
18. [Synthesis and analysis of cyclic analogs of angiotensin]. Antsans IuE; Bisenietse DA; Vosekalna IA; Myshliakova NV; Chipens GI Bioorg Khim; 1990 Mar; 16(3):358-69. PubMed ID: 2357239 [TBL] [Abstract][Full Text] [Related]
19. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor. Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 3H-Angiotensin II binding to zona glomerulosa cells by several analogs. Gurchinoff S; Khairallah PA Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):15-22. PubMed ID: 562643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]